Given the high levels of HDAC1 in these cells and our hypotheses that epigenetic regulation is key in driving pediatric liver tumors, we asked if HDAC inhibition might enhance cisplatin efficacy to inhibit the proliferation of hbl cells and reduce tumor cluster formation. The gene discussed is HDAC9; the disease is neoplasm.